ALPS Medical Breakthroughs ETF
SBIO
67 hedge funds and large institutions have $74M invested in ALPS Medical Breakthroughs ETF in 2020 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 4 closing their positions.
507% more call options, than puts
Call options by funds: $1.97M | Put options by funds: $324K
425% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 4
29% more funds holding
Funds holding: 52 → 67 (+15)
22% more capital invested
Capital invested by funds: $60.8M → $74M (+$13.2M)
14% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 14
5.49% less ownership
Funds ownership: 34.39% → 28.9% (-5.5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$510K |
| 2 |
VNA
Valley National Advisers
Bethlehem,
Pennsylvania
|
+$454K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$379K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$365K |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$364K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.87M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.87M |
| 3 |
GIA
Gladstone Institutional Advisory
Palm Beach Gardens,
Florida
|
-$494K |
| 4 |
EWA
Exencial Wealth Advisors
Oklahoma City,
Oklahoma
|
-$365K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$342K |
SBIO Hedge Fund Activity: Q4 2020 in Review
67 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2020, worth a combined $74M — up 22% from $60.8M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new SBIO positions and 4 closed out — a net gain of 17 holders — while 16 added to existing stakes and 14 trimmed.
The largest buyer was Cambridge Investment Research Advisors, opening a new position worth an estimated $510K. The largest seller was Royal Bank of Canada, cutting an estimated $1.87M.
- 67 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2020, up from 52 in Q3 2020.
- Funds reported $74M of ALPS Medical Breakthroughs ETF stock for Q4 2020, up 22% quarter-over-quarter.
- 21 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2020 and 4 closed out, a net change of +17 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q4 2020 was Cambridge Investment Research Advisors, an estimated $510K added.
- The largest ALPS Medical Breakthroughs ETF seller in Q4 2020 was Royal Bank of Canada, an estimated $1.87M sold.
Based on aggregated 13F filings for Q4 2020.